A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease

Clinical trial NCT03888716 · COMPLETED

Trial details

NCT number: NCT03888716
Sponsor: Abliva AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mitochondrial Diseases Mitochondrial Respiratory Chain Deficiencies MELAS Syndrome Mitochondrial Myopathies

Start date: 2019-03-18
Primary completion: 2021-03-16
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.